Skip to main content
. 2022 Aug 25;12(9):1372. doi: 10.3390/jpm12091372
AMI Acute myocardial infarction
AML Acute myeloid leukaemia
BMS Bare metal stent
CAD Coronary artery disease
CVD Cardiovascular disease
DCS Drug-coated stent
DAPT Dual antiplatelet therapy
DES Drug-eluting stent
FFR Fractional flow reserve
HBR High bleeding risk
ISR In-stent restenosis
MACE Major adverse cardiac events
MLA Minimum lumen areas
OCT Optical coherence tomography
OR Odds ratio
PCI Percutaneous coronary intervention
RR Relative risk
ST Stent thrombosis
TLR Target lesion revascularisation
TVR Target vessel revascularisation